UNSPSC 85563204: Revision of autologous tissue substitute in nose, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in nose, via natural or artificial opening endoscopic. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 09WK87Z

UNSPSC 85563204 Revision of autologous tissue substitute in nose, via natural or artificial opening endoscopic is a Commodity code showing minimal relevant recent state and local procurement activity. The code nominally describes a specific surgical procedure involving tissue grafting in nasal cavities, yet the six recent opportunities posted under this classification span occupational medical surveillance, disability medical evaluation services, pharmacy benefit management, temporary health professional staffing, surgical procedure carve-out networks, and emergency medical services for detained youth—none of which align with the code's stated scope of endoscopic nasal tissue revision. This mismatch suggests either systematic miscoding in the source data or a significant gap between the code's intended use and current state and local practice. State and local agencies do not appear to be actively procuring autologous tissue substitutes or related nasal surgical services under this code at present.

The opportunities tagged to this code originate from diverse issuing bodies including city governments (Phoenix, Long Beach), state transportation departments (Washington), county probation and health systems (Harris County, Collier County, Santa Clara County), and regional health authorities. Recent notices include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (due October 16, 2026), the Washington State Department of Transportation's RFP for occupational medical surveillance across 14 ferry terminals statewide (due October 9, 2026), the County of Santa Clara Health System's multiple-award RFSQ for temporary ancillary health professional staffing (due October 7, 2026), and Collier County's RFP for pharmacy benefit management covering approximately 2,400 enrolled employees and 4,800 covered dependents (originally due April 9, 2026). Geographic activity spans Arizona, California, Florida, and Washington. The absence of opportunities related to the code's nominal scope—nasal tissue revision procedures—indicates either a data anomaly or that state and local governments are not sourcing this service line through standard procurement channels under this classification.